ABSTRAa. The aim of this study was to determine whether intrauterine growth retardation (IUGR) is associated with an alteration in hepatic lipid metabolism. IUGR was induced in 25 guinea pigs by uterine artery ligation on gestational d 30. On d 62, after anesthesia, an infusion of [I-"Cj-palmitic acid was given. Fetuses were exposed at 15,30, and 45 min, and simultaneous maternal and umbilical venous blood samples were taken. Livers were divided into right lobe, right and left sublobes of the quadrate lobe, and left lobe. In control fetuses, plasma radiolipids rose in parallel with, but were about half the value of, maternal levels. In IUGR fetuses, plasma radiolipids were lower than in controls at 15 and 30 min but were comparable at 45 min. Most of the radiolipid in the maternal plasma was FFA, with only 6% incorporated into triglycerides at 45 min. In control and IUGR fetal plasmas, 36-37% of the radiolipid was triglycerides by 45 min. Radiolabel incorporation into the right lobe was less than into the left lobe and left half of the quadrate lobe in control and IUGR fetuses. Compared with controls, radiolabel incorporation in IUGR fetuses was less in some or all liver lobes at each time point. The proportion of label associated with FFA and triglycerides did not vary with time, between lobes, or between control and IUGR fetuses. The difference in uptake between lobes reflects their blood supply, implying that most FFA is extracted during the first passage of the umbilical venous blood. Growth retardation was not associated with compromised hepatic FFA metabolism. (Pediatr Res 32: 441-446, 1992) Abbreviations IUGR, intrauterine growth retardation TG, triacylglycerol tlc, thin-layer chromatography Asymmetric growth is seen in many neonates born small for gestational age and is a common feature of animal models of IUGR that rely upon a reduction in maternal placental blood flow (1-4). Development of the brain and cranium is favored at the expense of the appendicular skeleton and abdominal organs, notably the liver. This study was undertaken to determine
whether and to what extent this entails an alteration in hepatic lipid metabolism. Normally, FFA are taken up from the umbilical venous blood by the fetal liver and converted to TG, which then are secreted into the blood (5) (6) (7) .
The guinea pig is a useful model for studies of fetal lipid metabolism. In both the guinea pig and man, fat accounts for an appreciable share of body weight at birth (10% and 16%, respectively), and fat is an important substrate in the neonatal period (8) . IUGR can be induced in guinea pigs by ligating a uterine artery early in pregnancy (9). Less fat tissue is deposited in IUGR, and the concentration of TG in the liver is reduced as growth restriction becomes severe (2) . Because the growth-retarded guinea pig fetus is hypoglycemic (lo), it is possible that FFA are used to a greater extent in intermediary metabolism.
This study also afforded an opportunity to look for possible differences in lipid metabolism between the liver lobes during normal fetal growth and in IUGR. In the guinea pig, the entire umbilical venous return passes through the liver, but it is unevenly distributed between the liver lobes (1 I). This has not been taken into account in studies of TG synthesis by the fetal liver (7) . It could acquire particular significance in IUGR because it has long been known that liver damage in newborn babies occurs more frequently on the right side of the liver (12) .
MATERIALS AND METHODS
Twenty-five Dunkin-Hartley guinea pigs (M$llegaard, Lille Skensved, Denmark) were mated in our animal facility, where they were kept under controlled conditions (21°C, 55% relative humidity, and 12 h light cycle) in accordance with the European Convention for the Protection of Vertebrate Animals in Research. The animals were given free access to standard guinea pig food (Altromin, Brogaarden, Denmark), autoclaved meadow hay, and water. Ascorbic acid, a-tocopherol, and selenium (Tokosel vet., Pharmacia, Uppsala, Sweden) were added to the drinking water. Dated pregnancies were obtained by following a procedure similar to that described by Elvidge (1 3).
Intrauterine growth retardation was induced by ligating the uterine artery supplying one uterine horn at 30 d of pregnancy. The animals were premedicated with atropine (DAK, Copenhagen, Denmark; 0.05 mg s.c.) and xylazine (Rompun vet., Bayer, Germany; 3 mglkg intramuscularly) and anesthetized with ketamine (Ketalar, PD & Co., Moms Plains, NJ; 50 mglkg s.c.). The mesometrial fat pad of one uterine horn was exposed through a small abdominal incision, and the uterine artery or the uterine artery and vein embedded in it were ligated with surgical silk at the level of the cervix. Fetuses from this horn with a brain weightlliver weight ratio > 0.85 at the time of experiment were regarded as growth retarded. Fetuses from the contralateral horn with a ratio < 0.85 served as controls.
At 62 d of pregnancy, the animals were again premedicated with atropine and xylazine and anesthetized with ketamine (50
mg/kg intramuscularly). Catheters were inserted in a maternal carotid artery and jugular vein. [l-14C]-palmitic acid bound to human serum albumin and dissolved in saline was given by i.v. infusion. A stock solution of [l-14C]-palmitic acid, bound to human serum albumin, in physiologic saline solution was diluted to a concentration of 5 pCi/mL. The label was given by i.v. infusion at a constant rate of -5 mL/h (15.4 Bq/min per g maternal body wt). The precise infusion rate was determined both by calibrating the pump and by weighing the syringe before and after each infusion. A known volume of the infusate was kept for subsequent analysis. The total amount of palmitic acid given was 7.4 nmollmin.
After 15 min, a small incision was made in the abdomen and the uterine wall to expose the umbilical vein of one fetus. After venipuncture with a 27-gauge needle, -2 mL of blood were withdrawn from the umbilical vein. Immediately after, a 2-mL sample of maternal arterial blood was taken. The umbilical vein was tied off and the fetus removed and killed. The fetal liver was dissected out and divided into four parts: left lobe, quadrate lobe/ left sublobe, quadrate lobe/right sublobe (including the caudate lobe), and right lobe (14) . Each sample was weighed and frozen immediately in liquid N2. Blood was collected in chilled test tubes containing 2 mg EDTA and centrifuged for 10 min. The plasma phase was pipetted off and stored with the tissue samples at -80°C. This procedure was repeated for the remaining fetuses at intervals of -15 min, the infusion of isotope-labeled palmitic acid being continued throughout the experiment. After removal of the last fetus, the mother was killed and four 1-g samples were taken from the maternal liver: left lobe, quadrate lobelleft sublobe, quadrate lobe/right sublobe, and right lobe.
Plasma samples were extracted for total lipids in 3 volumes of chloroform-methanol (2: 1, vol/vol) with elution and evaporation of the subnatant. A known weight of each tissue was homogenized (Polytron, Kinematika Gmbh, Lucerne, Switzerland) with chloroform-methanol by the method of Folch et al. (15) using three washes with 0.02% (wt/vol) CaCI2. Aliquots of the plasma and tissue extracts were transferred to counting vials and dried down. After the addition of scintillation fluid (Optiscint Safe, LKB, Loughborough, UK), the samples were counted for Pemission in a liquid scintillation counter (LKB Rackbeta, LKB, Turku, Finland). The concentration of [l-14C]-labeled lipids in maternal and fetal plasma and the incorporation of label in the fetal liver were calculated, and the values were corrected for variations in infusion rate, as previously described (7) .
The distribution of radioactivity between FFA, TG, and other lipids was determined after separation by tlc. Aliquots taken from the plasma and tissue extracts were dissolved in chloroform and applied to tlc plates together with a mixture of standards. Separation was achieved with a mixture of hexane, ether, and acetic acid (140:60:2, vol/vol). Cholesterol, FFA, TG, and cholesterol esters were identified after staining with rhodamine. The bands were cut from the plates, and the radioactivity associated with various lipids was measured in a scintillation counter. To determine the incorporation of label into phospholipids, selected samples were separated by tlc with a mixture of chloroform, methanol, water, and acetic acid (65:25:4: 1, vol/vol).
Data analysis. The data analysis was performed using the Number Cruncher Statistical System (J. L. Hintze, Kaysville, UT). Changes in total activity and percentage incorporated into lipid classes with time in maternal and fetal plasma and the four lobes of the fetal liver were examined by one-way analysis of variance. Differences between liver lobes at each time point were examined by a similar procedure. Multiple comparisons were performed with Fisher's least significant difference test, using appropriately corrected probability values. Values in the text are means + SD.
RESULTS
Maternal arterial pH was 7.491 + 0.033, Pco2 was 5.46 f 0.28 kPa, Poz was 15.8 + 4.4 kPa, mean arterial blood pressure was 6.85 + 1.4 1 kPa (5 1.4 + 10.6 mm Hg), and heart rate was 198 + 1 1 bpm. Fetal morphometric data are shown in Table I .
Fifteen fetuses from the ligated horn were excluded from the study because they did not exhibit asymmetric growth (brain weightlliver weight ratio > 0.85). The 22 fetuses included in the study (60%) represent a proportion similar to that observed in an analysis of the outcome of 235 unilateral artery ligations (63%) (16 Table 2 ). In growth-retarded fetuses, the total concentration of label (F5.46 = 4.9, p < 0.01) and incorporation into TG (F5.46 = 9.8, p < 0.001) rose to significantly higher levels after 45 min ( Table 2 ). The amount of radioactivity associated with cholesterol (6.1-10.2%) and cholesterol esters (2.1-5.0%) did not vary significantly with time.
Control and IUGR fetuses are compared in Figure 1 . The total concentration of label in the plasma of IUGR fetuses was significantly lower than that in the corresponding controls at 15 and 30 min, and the percentage associated with FFA was significantly smaller in IUGR fetuses at 1 5 rnin (F5.46 = 4.1, p < 0.0 1).
Fetal liver. The [l-14C]-palmitic acid label was rapidly incorporated into the fetal liver ( Table 3 ). The right lobe of control and IUGR fetuses always contained significantly less radioactivity than the left lobe and the left half of the quadrate lobe (for controls F3.36 = 26.5 at 15 min, 15.5 at 30 min, and 17.7 at 45 min; for IUGR fetuses F3.24 = 8.8 at 15 min, 7.7 at 30 min, and F3.28 = 1 8.5 at 45 min; p < 0.00 1 throughout). It also incorporated less label than the right half of the quadrate lobe in control fetuses at each time point and IUGR fetuses at 45 min. In addition, the right half of the quadrate lobe differed significantly from the left half of the quadrate lobe and from the left lobe in control and IUGR fetuses at 15 rnin and IUGR fetuses at 45 min and from the left lobe in control and IUGR fetuses at 30 min (all p < 0.05).
Compared to controls, IUGR fetuses had incorporated significantly less radioactivity in the right lobe (t = 3.1, p < 0.01) and right half of the quadrate lobe (t = 4.1, p < 0.001) at 15 min, in all liver lobes at 30 min (right lobe, t = 4.0, p < 0.01; right quadrate lobe, t = 4.1, p < 0.001; left quadrate lobe, t = 2.4, p < 0.05; left lobe t = 3.4, p < 0.01), and in the right sublobe of the quadrate lobe at 45 rnin (t = 3.6, p < 0.0 1).
Incorporation of [14C]-radioactivity by the various liver lobes into FFA, TG, cholesterol esters, and cholesterol is shown in Figure 2 . There were no significant differences between liver lobes, and no variation with time, in the proportions of FFA and TG. Incorporation of label in cholesterol esters was greater in the right lobe than in the other lobes of the liver in controls at 
DISCUSSION
In the guinea pig, FFA is rapidly transferred from maternal to fetal blood, sequestered by the liver, and converted to TG (5) (6) (7) .
The results of the present study indicate important differences in FFA sequestration between the various liver lobes of both control and IUGR fetuses that can be related to differences in blood supply, supporting the view that most FFA is extracted at the first passage through the liver. Overall, transfer and assimilation of FFA did not appear to be compromised in the growthretarded fetus.
IUGR was induced by uterine artery ligation (1, 9). The resultant growth restriction is regarded as a model for human type I1 IUGR, in which body weight is affected more than length and the brain is spared at the expense of the abdominal organs (17) . However, fetal growth is not always impaired by the procedure (l6), and therefore we have arbitrarily defined an IUGR 444 DETMER ET AL. fetus as one with a brain weight/liver weight ratio > 0.85. In this group of fetuses, brain weight was reduced by 13%, whereas the overall decrease in liver weight was 52%. In accordance with our previous findings (1 8), the liver lobes were unequally affected; the decrease in weight was 60% for the right lobe compared to 47% for the left lobe.
The total radioactivity in the maternal plasma increased significantly at each time point during the 45-min infusion of [l-'4C]-palmitate, indicating that we did not reach a steady state for radiolabeled palmitate. This was probably due to the lack of an initial bolus injection of label and the reemergence of radiolipid from fat stores in the dam during the course of the experiment. Inasmuch as unlabeled lipid was given in tracer amounts (7.4 nmol/min), the animals would have been in steady state for cold fat. In agreement with a previous study (7), most of the label was associated with FFA, with only modest incorporation in TG and other lipids.
Fetal plasma concentrations of the label rose gradually in control fetuses, but there was a slower rise with time in IUGR fetuses. This could be related to the lower rate of blood flow and thus of fatty acid delivery to the placentas of IUGR fetuses. However, a reduction in placental transfer capacity, analogous to that observed for a-aminoisobutyric acid (19) , cannot be excluded.
If it is assumed that the placental transfer of FFA is to a certain extent blood flow dependent, it becomes important to recognize that maternal placental blood flow is reduced by ketaminexylazine anesthesia (20) . However, this effect of the anesthetic depends on a change in cardiac output rather than in placental vascular resistance and can be completely reversed by infusion of isoproterenol (20) . Therefore, it is likely that any effect of the anesthetic on placental blood flow in our study would affect control and IUGR fetuses equally.
A further potential source of error is the effect of maternal blood sampling on maternal hemodynamics. We removed at most three fetuses from each dam, and cumulative maternal blood loss before removal of the third fetus was 5 mL or about 7% of the estimated maternal blood volume (2 1). Fluid replacement over the same period, including the volume of the infusate, totaled 7 mL.
Previous studies have demonstrated a considerable concentration gradient for labeled FFA between fetal arterial blood and umbilical venous blood (6) , suggesting that FFA are taken up during the first passage of the blood through the liver. This interpretation receives further support from the differences in uptake observed in this study between liver lobes (Table 3) , as they can be related to differences in the blood supply of the lobes.
The ductus venosus is absent in the latter part of pregnancy in the guinea pig (22) , and the entire umbilical venous return passes through the liver. It is, however, unevenly distributed between the liver lobes because the umbilical vein supplies the left lobe and the left sublobe of the quadrate lobe, whereas the right lobe and most of the right sublobe of the quadrate lobe are supplied by the portal vein. Consequently, if radioactive microspheres are injected in the umbilical vein, most are recovered from the left half of the liver (1 I), whereas microspheres injected in a branch of the portal vein are found almost exclusively in the right lobe and the right sublobe of the quadrate lobe (18) . Therefore, if FFA are sequestered from the umbilical venous blood at the first passage through the liver, there should be greater uptake of label by the left half of the liver than by the right lobe, with the right sublobe of the quadrate lobe occupying an intermediate position.
This pattern was observed in control and IUGR fetuses (Table  3) . There was no difference in acquisition of label between the corresponding lobes of the maternal liver.
Differences in the blood supply to the two halves of the liver are believed to account for nonsiderotic hemilateral liver degeneration, which occurs with a frequency of 3.6% in infants that die in the perinatal period (23) . The anomaly is found on the right side of the liver, in the area supplied by the portal vein, and has been ascribed to prolonged anoxia in which the oxygenation of this side of the liver becomes even more unfavorable, resulting in injury to the hepatic cells (12, 23) .
The tendency was for less radioactivity to be incorporated by the livers of IUGR fetuses at 15 and 30 min, but by 45 min these differences had largely disappeared. Once again, the slower accumulation of label probably reflects reduced fatty acid delivery to the placenta and possibly a lower placental transfer capacity for FFA. IUGR has recently been shown to be associated with a reduction in the activity of a tissue lipase within the rat placenta (24) , which will affect the rate of TG hydrolysis and FFA release, thereby slowing the apparent flux through this "pool." The placentas of SGA babies have an unaltered total TG content, although the proportions of 16:O and 18:O fatty acids are greater in SGA placentas, with corresponding reductions in fatty acids of the linoleic acid series (25) . It was recognized that these changes could lead to altered fatty acid transport to the fetal compartment, but measurements of the phosphatidylcholine fatty acid composition of cord plasma revealed little difference between small for gestational age and appropriate for gestational age babies, indicating that placental transfer of fatty acid is not greatly impaired in human IUGR (25) .
Fatty liver and hyperlipemia are normal characteristics of the guinea pig fetus (26) and are in part due to the absence of lipoprotein lipase on the fetal side of the placenta (27) . In the IUGR fetus, histologic examination indicates that the right lobe of the liver, which accounts for a relatively smaller proportion of liver weight, undergoes fatty degeneration (Ernst L, personal communication). Uptake of label by this lobe in IUGR fetuses was 45% or less of that in controls at 15 and 30 min.
is an important fuel source for pre-and postnatal metabolism.
minutes
The growth-retarded guinea pig fetus is hypoglycemic (10) and therefore may consume TG to a greater extent. The rate of fat deposition is clearly less than normal in the growth-restricted fetus and total perirenal fat is halved (2), although fat stores per g of body weight probably are not less at birth than in the normal fetus (2) .
In conclusion, the observations of reduced FFA uptake made in this study may help to explain why total body fat is reduced in low birth weight infants (28). However, further studies on the rate of lipid turnover in IUGR fetuses are needed to enhance our understanding of this phenomenon. The liver was divided into the right lobe, right half of the quadrate lobe, left half of the quadrate lobe, and left lobe.
In the fetal liver, approximately 55% of the label was incorporated into TG. In comparable studies lasting up to 160 min, there was a linear increase in incorporation of label into hepatic TG with time (7), but this was not seen over the shorter time course of the present experiments. The percentage of label associated with TG was similar in control and IUGR fetuses. However, in fetal plasma, incorporation into TG rose with time in control and IUGR fetuses and reached about 35% in both groups after 45 min, a figure comparable to that previously reported (7) .
In comparing IUGR with control fetuses, the reduction in size of the liver must be considered, as it is greater than the reduction in body weight. Total uptake of label and synthesis of hepatic TG was smaller in IUGR fetuses at all time points. Hepatic TG
